机译:Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
Department of Pulmonary Medicine Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai 200030 China;
Department of Internal Medicine Shandong Cancer Hospital Affiliated to Shandong University Jinan 250117 China;
Department of Oncology Affiliated Hospital of Jiang Nan University Wuxi 214122 China;
Department of Internal Medicine Henan Province Tumor Hospital Zhengzhou University Zhengzhou 450008 China;
Department of Thoracic Oncology Ⅱ Peking University Cancer Hospital and Institute Beijing 100142 China;
Department of Oncology Chinese PLA General Hospital Beijing 100039 China;
Department of Oncology Qilu Hospital of Shandong University Jinan 250012 China;
Department of Clinical Research Centre Qilu Pharmaceutical Co. Ltd Jinan 250101 China;
Department of Thoracic Oncology Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin's Clinical Research Center for Cancer Tianjin 300060 China;
Department of Pulmonary Medicine Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai 200030 China;
Department of Pulmonary Medicine Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai 200030 China;
Department of Oncology The First Affiliated Hospital of Bengbu Medical College Bengbu 233004 China;
Department of Oncology Tangdu Hospital Air Force Medical University of PLA Xi'an 710038 China;
Department of Medical Thoracic Oncology Fujian Cancer Hospital Fujian Medical University Cancer Hospital Fuzhou 350014 China;
Department of Oncology Harbin Medical University Cancer Hospital Harbin 150081 China;
Department of Oncology Linyi Cancer Hospital Linyi 276000 China;
Department of Oncology The Second Hospital of Anhui Medical University Hefei 230601 China;
Department of Oncology The Affiliated Hospital of Qingdao University Qingdao 266071 China;